- Home
- CNSP vs UCAR Comparison
CNSP vs UCAR Comparison
Compare CNSP & UCAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNSP | UCAR |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 6.9M |
| IPO Year | 2019 | 2022 |
Fundamental Metrics
Financial Performance| Metric | CNSP | UCAR |
|---|---|---|
| Price | $3.64 | $2.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 16.2K | 7.7K |
| Earning Date | 11-24-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $8.51 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.90 | $0.04 |
| 52 Week High | $10.54 | $8.99 |
Technical Indicators
Market Signals| Indicator | CNSP | UCAR |
|---|---|---|
| Relative Strength Index (RSI) | 32.27 | 44.19 |
| Support Level | $2.01 | $1.05 |
| Resistance Level | $5.75 | $4.87 |
| Average True Range (ATR) | 0.53 | 0.33 |
| MACD | -0.09 | -0.02 |
| Stochastic Oscillator | 1.09 | 49.40 |
Price Performance
Historical ComparisonAbout CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
About UCAR U Power Limited
U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.